Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic Gears Up For FDA Panel With Mixed Results From AF Ablation Trial

This article was originally published in The Gray Sheet

Executive Summary

Medtronic could face more questions than expected at an FDA advisory panel meeting later this month for the firm’s Phased RF Ablation System for atrial fibrillation due to mixed pivotal trial results released last week.

You may also be interested in...

Safety Concerns Sink Medtronic A-Fib Catheter Ablation System At Panel

Risks associated with Medtronic’s Phased RF catheter ablation system for atrial fibrillation outweigh the benefits of the device, FDA’s Circulatory System Devices panel concluded in an 8-2 vote on Oct. 27.

Medtronic Makes Another Big Play In A-Fib, Purchases Ablation Frontiers

Medtronic will add anatomically designed radiofrequency ablation catheters for treatment of atrial fibrillation to its fledgling AF Solutions division through the purchase of privately held Ablation Frontiers

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts